ES2946177T3 - Proceso para la preparación de compuestos opioides - Google Patents
Proceso para la preparación de compuestos opioides Download PDFInfo
- Publication number
- ES2946177T3 ES2946177T3 ES15726407T ES15726407T ES2946177T3 ES 2946177 T3 ES2946177 T3 ES 2946177T3 ES 15726407 T ES15726407 T ES 15726407T ES 15726407 T ES15726407 T ES 15726407T ES 2946177 T3 ES2946177 T3 ES 2946177T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- formula
- amount
- range
- molar equivalents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461988523P | 2014-05-05 | 2014-05-05 | |
| US14/689,712 US9701688B2 (en) | 2014-05-05 | 2015-04-17 | Process for the preparation of opioid compounds |
| PCT/US2015/027912 WO2015171354A2 (en) | 2014-05-05 | 2015-04-28 | Process for the preparation of opioid compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2946177T3 true ES2946177T3 (es) | 2023-07-13 |
Family
ID=54354748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15726407T Active ES2946177T3 (es) | 2014-05-05 | 2015-04-28 | Proceso para la preparación de compuestos opioides |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9701688B2 (en:Method) |
| EP (1) | EP3140308B8 (en:Method) |
| JP (2) | JP6792745B2 (en:Method) |
| CN (1) | CN107001381A (en:Method) |
| AU (3) | AU2015256416B2 (en:Method) |
| CA (2) | CA2947012C (en:Method) |
| DK (1) | DK3140308T3 (en:Method) |
| ES (1) | ES2946177T3 (en:Method) |
| WO (1) | WO2015171354A2 (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201716830D0 (en) | 2017-10-13 | 2017-11-29 | Cambrex Charles City Inc | New Process |
| WO2023102489A1 (en) * | 2021-12-03 | 2023-06-08 | Board Of Regents Of The University Of Nebraska | Compounds, nanoparticles, and pharmaceutical compositions for the treatment of drug addiction |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3474101A (en) | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
| CA2674915C (en) | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
| US20080125592A1 (en) | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
| WO2008064351A2 (en) | 2006-11-22 | 2008-05-29 | Progenics Pharmaceuticals, Inc. | (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs |
| EP2152715B1 (en) * | 2007-05-04 | 2010-12-29 | Mallinckrodt Inc. | Improved process for the preparation of 6-alpha-hydroxy-n-alkylated opiates |
| US8962841B2 (en) | 2007-06-29 | 2015-02-24 | Brock University | Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids |
| CN101861315B (zh) | 2007-11-20 | 2013-01-16 | 日产化学工业株式会社 | 2-氮杂金刚烷类的制造方法 |
| CA2720034A1 (en) * | 2008-03-31 | 2009-10-08 | Sun Pharmaceutical Industries Ltd. | An improved process for the preparation of morphinane analogues |
| WO2010017573A1 (en) | 2008-08-11 | 2010-02-18 | Tasmanian Alkaloids Pty Limited | PROCESS FOR MAKING MORPHINAN-6α-OLS |
| WO2010039209A2 (en) | 2008-09-30 | 2010-04-08 | Mallinckrodt Inc. | Processes for the synthesis of tertiary amines |
| CA2738250C (en) | 2008-09-30 | 2018-08-14 | Mallinckrodt Inc. | Processes for increasing the yield of the hydrolysis of the 3-o-methyl and 17-n-nitrile group in the preparation of opiate alkaloid derivatives |
| ES2477190T3 (es) | 2008-09-30 | 2014-07-16 | Mallinckrodt Llc | Procedimiento de reciclaje para aumentar el rendimiento de una reacción de Grignard en la preparación de derivados alcaloides opiáceos |
| WO2010039210A1 (en) | 2008-09-30 | 2010-04-08 | Mallinckrodt Inc. | Processes for the hydrogenation of opiate alkaloid derivatives |
| PL2342207T3 (pl) | 2008-09-30 | 2016-05-31 | SpecGx LLC | Sposoby alkilowania norbuprenorfiny ze zmniejszonym powstawaniem zanieczyszczeń |
| WO2010096416A1 (en) | 2009-02-17 | 2010-08-26 | Mallinckrodt Inc. | Process for the reductive alkylation of normorphinans |
| NZ595591A (en) | 2009-04-24 | 2013-11-29 | Univ Brock | Processes for the preparation of morphinane and morphinone compounds |
| US20110269964A1 (en) * | 2010-04-29 | 2011-11-03 | Mallinckrodt Inc. | N-Alkylation of Opiates |
| TWI471289B (zh) * | 2010-06-11 | 2015-02-01 | Rhodes Technologies | 使三級胺進行n-脫烷反應之方法 |
| SMT201700177T1 (it) * | 2010-11-05 | 2017-05-08 | H Lundbeck As | Procedimento per la fabbricazione di naltrexone |
| JP6046119B2 (ja) | 2011-05-02 | 2016-12-14 | ブロック ユニバーシティ | 脱水環化試薬を使用するn−オキシドのn−脱メチル化によるモルヒネ類似体の調製における方法および中間体 |
| HUE040284T2 (hu) | 2011-10-03 | 2019-02-28 | Johnson Matthey Plc | Eljárás buprenorfin elõállítására |
| AU2013214667A1 (en) | 2012-02-03 | 2014-09-25 | Brock University | Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans |
| US20140155608A1 (en) * | 2012-05-03 | 2014-06-05 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
-
2015
- 2015-04-17 US US14/689,712 patent/US9701688B2/en active Active
- 2015-04-28 CN CN201580035299.7A patent/CN107001381A/zh active Pending
- 2015-04-28 ES ES15726407T patent/ES2946177T3/es active Active
- 2015-04-28 CA CA2947012A patent/CA2947012C/en active Active
- 2015-04-28 EP EP15726407.8A patent/EP3140308B8/en active Active
- 2015-04-28 JP JP2016565669A patent/JP6792745B2/ja active Active
- 2015-04-28 WO PCT/US2015/027912 patent/WO2015171354A2/en not_active Ceased
- 2015-04-28 DK DK15726407.8T patent/DK3140308T3/da active
- 2015-04-28 AU AU2015256416A patent/AU2015256416B2/en active Active
- 2015-04-28 CA CA3208298A patent/CA3208298A1/en active Pending
-
2018
- 2018-06-05 AU AU2018203948A patent/AU2018203948B2/en active Active
-
2020
- 2020-02-12 JP JP2020021254A patent/JP2020073598A/ja active Pending
- 2020-03-19 AU AU2020201990A patent/AU2020201990A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018203948B2 (en) | 2019-12-19 |
| CA2947012A1 (en) | 2015-11-12 |
| CA2947012C (en) | 2023-09-26 |
| EP3140308B1 (en) | 2023-05-24 |
| CN107001381A (zh) | 2017-08-01 |
| US20150315205A1 (en) | 2015-11-05 |
| CA3208298A1 (en) | 2015-11-12 |
| JP6792745B2 (ja) | 2020-12-02 |
| WO2015171354A2 (en) | 2015-11-12 |
| AU2015256416B2 (en) | 2018-03-08 |
| AU2018203948A1 (en) | 2018-06-21 |
| DK3140308T3 (da) | 2023-06-19 |
| WO2015171354A3 (en) | 2016-03-17 |
| AU2020201990A1 (en) | 2020-04-09 |
| EP3140308B8 (en) | 2023-06-28 |
| EP3140308A2 (en) | 2017-03-15 |
| JP2017514846A (ja) | 2017-06-08 |
| US9701688B2 (en) | 2017-07-11 |
| AU2015256416A1 (en) | 2016-11-24 |
| JP2020073598A (ja) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240368192A1 (en) | Nitrogen-Containing Heterocyclic Compound, and Preparation Method Therefor, Intermediate Thereof, and Application Thereof | |
| US20230271976A1 (en) | Opioid receptor modulators | |
| JP2021501191A (ja) | Wee1阻害剤としての大環状化合物及びその使用 | |
| JP2019503383A5 (en:Method) | ||
| JP3117777B2 (ja) | チエノピリジン誘導体 | |
| US20200317660A1 (en) | Quinazolinone Compound and Application Thereof | |
| ES2946177T3 (es) | Proceso para la preparación de compuestos opioides | |
| WO2007104214A1 (en) | Camptothecin derivatives and their use | |
| AU2015256507B2 (en) | Process for the preparation of opioid compounds | |
| JP2025532843A (ja) | 抗がん核内ホルモン受容体標的化化合物 | |
| US11591314B2 (en) | Process for preparing tetrahydrocarbazole carboxamide compound | |
| US10287296B2 (en) | Process for the preparation of (S)-2-((4R,4aS,6R,7R,7aR,12bS)-7,9-dimethoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-6-yl)-3,3-dimethylbutan-2-ol | |
| US10131660B2 (en) | Tetrahydro-azepinoquinolines as agonists of the 5-HT2C receptor |